Biocode Corp News Today

Applied BioCode Corp (ABC, 瑞磁生技) expects that the emergency use authorization it has obtained from the US Food and Drug Administration (FDA) for a COVID-19 test kit would spur revenue growth next year, the firm said yesterday. The kit, which tests for COVID-19 and flu, has been supplied to more than 10 hospitals in the US, it said. The new product would generate a rise in revenue next month at the earliest, ABC vice president Nick Chen (陳祐寧) told the Taipei Times by telephone. Whi...